(Q64360174)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

title

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Javier A Jaimes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

author name string

Tiffany Tang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Lakshmi Nathan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Hung-Lun Hsu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Susan Daniel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Gary R Whittaker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

language of work or name

English

0 references

publication date

1 March 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

Journal of Visualized Experiments

29 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

issue

145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

29 April 2020

cites work

1 reference

12 December 2020

A system for functional analysis of Ebola virus glycoprotein

1 reference

12 December 2020

Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.

1 reference

12 December 2020

Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles

1 reference

12 December 2020

Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism

1 reference

12 December 2020

Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production

1 reference

12 December 2020

Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo

1 reference

12 December 2020

The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication

1 reference

12 December 2020

Functional murine leukemia virus vectors pseudotyped with the visna virus envelope show expanded visna virus cell tropism

1 reference

12 December 2020

Coreceptor Switch of [MLV(SIVagm)] pseudotype vectors by V3-loop exchange.

1 reference

12 December 2020

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

1 reference

12 December 2020

Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test

1 reference

12 December 2020

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

1 reference

12 December 2020

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

1 reference

12 December 2020

The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex

1 reference

12 December 2020

Characterization of functional hepatitis C virus envelope glycoproteins.

1 reference

12 December 2020

Virus entry: molecular mechanisms and biomedical applications

1 reference

12 December 2020

Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein

1 reference

12 December 2020

Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein

1 reference

12 December 2020

Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression

1 reference

12 December 2020

Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.

1 reference

12 December 2020

EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus

1 reference

12 December 2020

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

1 reference

12 December 2020

Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses

1 reference

12 December 2020

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

1 reference

12 December 2020

Type I feline coronavirus spike glycoprotein fails to recognize aminopeptidase N as a functional receptor on feline cell lines

1 reference

12 December 2020

Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein.

1 reference

12 December 2020

Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme

1 reference

12 December 2020

Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies

1 reference

12 December 2020

Single-particle kinetics of influenza virus membrane fusion

1 reference

12 December 2020

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

1 reference

12 December 2020

Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide

1 reference

12 December 2020

Characterization of Chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein

1 reference

12 December 2020

SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion

1 reference

12 December 2020

Involvement of Ceramide in the Propagation of Japanese Encephalitis Virus

1 reference

12 December 2020

Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain

1 reference

12 December 2020

TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.

1 reference

12 December 2020

Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines

1 reference

12 December 2020

Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease

1 reference

12 December 2020

(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry

1 reference

12 December 2020

Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase

1 reference

12 December 2020

Mechanisms of coronavirus cell entry mediated by the viral spike protein

1 reference

12 December 2020

The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies

1 reference

12 December 2020

Membrane fusion-competent virus-like proteoliposomes and proteinaceous supported bilayers made directly from cell plasma membranes.

1 reference

12 December 2020

Single particle assay of coronavirus membrane fusion with proteinaceous receptor-embedded supported bilayers

1 reference

12 December 2020

A novel activation mechanism of avian influenza virus H9N2 by furin.

1 reference

12 December 2020

Detection of antibodies against H5 and H7 strains in birds: evaluation of influenza pseudovirus particle neutralization tests.

1 reference

12 December 2020

Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus

1 reference

12 December 2020

Pseudotyping of vesicular stomatitis virus with the envelope glycoproteins of highly pathogenic avian influenza viruses

1 reference

12 December 2020

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

1 reference

12 December 2020

Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis

1 reference

12 December 2020

Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.

1 reference

12 December 2020

An optimised method for the production of MERS-CoV spike expressing viral pseudotypes

1 reference

12 December 2020

Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies

1 reference

12 December 2020

Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin

1 reference

12 December 2020

Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles.

1 reference

12 December 2020

Viral fusion efficacy of specific H3N2 influenza virus reassortant combinations at single-particle level.

1 reference

12 December 2020

A camel-derived MERS-CoV with a variant spike protein cleavage site and distinct fusion activation properties

1 reference

12 December 2020

Murine Leukemia Virus (MLV)-based Coronavirus Spike-pseudotyped Particle Production and Infection

1 reference

12 December 2020

The SARS-CoV Fusion Peptide Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium-Dependent Manner

1 reference

12 December 2020

Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells.

1 reference

12 December 2020

HCoV-229E spike protein fusion activation by trypsin-like serine proteases is mediated by proteolytic processing in the S2′ region

1 reference

12 December 2020

Identifiers

DOI

10.3791/59010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30882796%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

PubMed publication ID

30882796

1 reference